Literature DB >> 9914179

Negative control elements of the cell cycle in human tumors.

P D Adams1, W G Kaelin.   

Abstract

The retinoblastoma protein and p53 are both cell-cycle regulators and are, directly or indirectly, inactivated in the majority of human tumors. Recent studies have provided new mechanistic insights into how these proteins regulate cell growth in response to various intracellular and extracellular signals.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9914179     DOI： 10.1016/s0955-0674(98)80123-3

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN： 0955-0674            Impact factor:   8.382


  8 in total

1.  Choosing anticancer drug targets in the postgenomic era.

Authors:  W G Kaelin
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells.

Authors:  Jin Ding; Ronghe Zhang; Jingxia Li; Caifang Xue; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

3.  Loss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development.

Authors:  Ramon Roca; Robert M Kypta; Maria d M Vivanco
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

4.  Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.

Authors:  Kyung-Soo Chun; Jacqueline K Akunda; Robert Langenbach
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

5.  Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Authors:  Keith L Ligon; Emmanuelle Huillard; Shwetal Mehta; Santosh Kesari; Hongye Liu; John A Alberta; Robert M Bachoo; Michael Kane; David N Louis; Ronald A Depinho; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

Review 6.  p53 in rheumatoid arthritis: friend or foe?

Authors:  U Müller-Ladner; K Nishioka
Journal:  Arthritis Res       Date:  2000-03-31

7.  The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer.

Authors:  Sabrina T Reis; Luciana S Timoszczuk; José Pontes-Junior; Nayara Viana; Iran A Silva; Nelson Dip; Miguel Srougi; Katia R M Leite
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

8.  Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting.

Authors:  Huiqing Liu; Weiji Weng; Rongjun Guo; Jie Zhou; Jun Xue; Shan Zhong; Jinke Cheng; Michael X Zhu; Si-Jian Pan; Yong Li
Journal:  Cell Death Differ       Date:  2020-06-01       Impact factor: 15.828
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.